Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Common Equity (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Common Equity for 10 consecutive years, with $16.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Common Equity fell 7.15% to $16.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $16.5 million, a 7.15% decrease, with the full-year FY2024 number at $16.8 million, down 17.39% from a year prior.
  • Common Equity was $16.5 million for Q3 2025 at KORU Medical Systems, roughly flat from $16.5 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $37.8 million in Q1 2021 to a low of $16.3 million in Q1 2025.
  • A 5-year average of $26.7 million and a median of $28.1 million in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: soared 211.43% in 2021, then plummeted 35.84% in 2024.
  • KORU Medical Systems' Common Equity stood at $36.5 million in 2021, then dropped by 14.18% to $31.3 million in 2022, then tumbled by 35.03% to $20.4 million in 2023, then fell by 17.39% to $16.8 million in 2024, then decreased by 2.07% to $16.5 million in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Common Equity are $16.5 million (Q3 2025), $16.5 million (Q2 2025), and $16.3 million (Q1 2025).